Experimental Drug May Boost Leukemia Survival, Without Chemo
Idelalisib is being fast-tracked for FDA approval for use in patients with chronic lymphocytic leukemiaContinue Reading
Idelalisib is being fast-tracked for FDA approval for use in patients with chronic lymphocytic leukemiaContinue Reading
Headband-like unit stimulates nerve associated with painful headachesContinue Reading
Wearable headband uses electrodes to stimulate nerve tied to the headachesContinue Reading
Enrollment period for coverage in 2014 ends March 31 for most AmericansContinue Reading
Enrollment period for coverage in 2014 ends March 31 for most AmericansContinue Reading
Risk rises with multiple ER visits, researchers sayContinue Reading
Gap projected to reach nearly 1,500 specialists in a decade, American Society of Clinical Oncology cautionsContinue Reading
Study found they were more than twice as likely to end up in ER, five times more likely to be hospitalizedContinue Reading
Study found they were more than twice as likely to end up in ER, five times more likely to be hospitalizedContinue Reading
Schools that had more repeaters had more suspensions, other signs of trouble in student bodyContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.